Encompass Health Corporation Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest
Encompass Health Corporation (EHC) reported Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest of $204.30 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Shareholders' Equity
us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest · last filed 2026-08-07
- Encompass Health Corporation net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2026-06-30 was $204.30M, a 11.70% increase year-over-year.
- Encompass Health Corporation net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2026-03-31 was $245.50M, a 26.48% increase year-over-year.
- Encompass Health Corporation net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2025-12-31 was $200.00M, a 22.47% increase year-over-year.
- Encompass Health Corporation net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2025-09-30 was $172.70M, a 18.37% increase year-over-year.
- Encompass Health Corporation net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2025 was $749.70M, a 26.75% increase from fiscal 2024.
- Encompass Health Corporation net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2024 was $591.50M, a 30.09% increase from fiscal 2023.
- Encompass Health Corporation net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2023 was $454.70M, a 26.76% increase from fiscal 2022.
- Encompass Health Corporation net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2022 was $358.70M, a 29.42% decline from fiscal 2021.
| Period end | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 12 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $204.30M 10-Q · filed 2026-08-07 | $449.80M 10-Q · filed 2026-08-07 | $649.80M derived: sum of 3 quarters · filed 2026-08-07 | $822.50M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2026-03-31 | $245.50M 10-Q · filed 2026-05-01 | $445.50M derived: sum of 2 quarters · filed 2026-05-01 | $618.20M derived: sum of 3 quarters · filed 2026-05-01 | $801.10M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-12-31 | $200.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $372.70M derived: sum of 2 quarters · filed 2026-02-26 | $555.60M derived: sum of 3 quarters · filed 2026-08-07 | $749.70M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $172.70M 10-Q · filed 2025-10-31 | $355.60M derived: sum of 2 quarters · filed 2026-08-07 | $549.70M 10-Q · filed 2025-10-31 | $713.00M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-06-30 | $182.90M 10-Q · filed 2026-08-07 | $377.00M 10-Q · filed 2026-08-07 | $540.30M derived: sum of 3 quarters · filed 2026-08-07 | $686.20M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-03-31 | $194.10M 10-Q · filed 2026-05-01 | $357.40M derived: sum of 2 quarters · filed 2026-05-01 | $503.30M derived: sum of 3 quarters · filed 2026-05-01 | $648.30M derived: sum of 4 quarters · filed 2026-05-01 | |
| 2024-12-31 | $163.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $309.20M derived: sum of 2 quarters · filed 2026-02-26 | $454.20M derived: sum of 3 quarters · filed 2026-02-26 | $591.50M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $145.90M 10-Q · filed 2025-10-31 | $290.90M derived: sum of 2 quarters · filed 2025-10-31 | $428.20M 10-Q · filed 2025-10-31 | $545.20M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $145.00M 10-Q · filed 2025-08-06 | $282.30M 10-Q · filed 2025-08-06 | $399.30M derived: sum of 3 quarters · filed 2026-02-26 | $510.80M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $137.30M 10-Q · filed 2025-05-01 | $254.30M derived: sum of 2 quarters · filed 2026-02-26 | $365.80M derived: sum of 3 quarters · filed 2026-02-26 | $480.80M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $117.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $228.50M derived: sum of 2 quarters · filed 2026-02-26 | $343.50M derived: sum of 3 quarters · filed 2026-02-26 | $454.70M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $111.50M 10-Q · filed 2024-11-01 | $226.50M derived: sum of 2 quarters · filed 2024-11-01 | $337.70M 10-Q · filed 2024-11-01 | $453.00M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-06-30 | $115.00M 10-Q · filed 2024-08-06 | $226.20M 10-Q · filed 2024-08-06 | $341.50M derived: sum of 3 quarters · filed 2025-02-28 | $406.90M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-03-31 | $111.20M 10-Q · filed 2024-05-02 | $226.50M derived: sum of 2 quarters · filed 2025-02-28 | $291.90M derived: sum of 3 quarters · filed 2025-02-28 | $361.70M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2022-12-31 | $115.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $180.70M derived: sum of 2 quarters · filed 2025-02-28 | $250.50M derived: sum of 3 quarters · filed 2025-02-28 | $358.70M 10-K · filed 2025-02-28 | |
| 2022-09-30 | $65.40M 10-Q · filed 2023-11-01 | $135.20M derived: sum of 2 quarters · filed 2023-11-01 | $243.40M 10-Q · filed 2023-11-01 | $357.40M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-06-30 | $69.80M 10-Q · filed 2023-08-04 | $178.00M 10-Q · filed 2023-08-04 | $292.00M derived: sum of 3 quarters · filed 2024-02-28 | $416.50M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-03-31 | $108.20M 10-Q · filed 2023-05-03 | $222.20M derived: sum of 2 quarters · filed 2024-02-28 | $346.70M derived: sum of 3 quarters · filed 2024-02-28 | $486.00M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2021-12-31 | $114.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $238.50M derived: sum of 2 quarters · filed 2024-02-28 | $377.80M derived: sum of 3 quarters · filed 2024-02-28 | $508.20M 10-K · filed 2024-02-28 | |
| 2021-09-30 | $124.50M 10-Q · filed 2022-11-02 | $263.80M derived: sum of 2 quarters · filed 2022-11-02 | $394.20M 10-Q · filed 2022-11-02 | $504.20M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-06-30 | $139.30M 10-Q · filed 2022-08-04 | $269.70M 10-Q · filed 2022-08-04 | $379.70M derived: sum of 3 quarters · filed 2023-02-27 | $477.60M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-03-31 | $130.40M 10-Q · filed 2022-05-03 | $240.40M derived: sum of 2 quarters · filed 2023-02-27 | $338.30M derived: sum of 3 quarters · filed 2023-02-27 | $385.10M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2020-12-31 | $110.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $207.90M derived: sum of 2 quarters · filed 2023-02-27 | $254.70M derived: sum of 3 quarters · filed 2023-02-27 | $361.40M 10-K · filed 2023-02-27 | |
| 2020-09-30 | $97.90M 10-Q · filed 2021-11-02 | $144.70M derived: sum of 2 quarters · filed 2021-11-02 | $251.40M 10-Q · filed 2021-11-02 | $339.10M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-06-30 | $46.80M 10-Q · filed 2021-08-03 | $153.50M 10-Q · filed 2021-08-03 | $241.20M derived: sum of 3 quarters · filed 2022-02-25 | $357.00M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-03-31 | $106.70M 10-Q · filed 2021-05-04 | $194.40M derived: sum of 2 quarters · filed 2022-02-25 | $310.20M derived: sum of 3 quarters · filed 2022-02-25 | $418.70M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2019-12-31 | $87.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $203.50M derived: sum of 2 quarters · filed 2022-02-25 | $312.00M derived: sum of 3 quarters · filed 2022-02-25 | $433.20M 10-K · filed 2022-02-25 | |
| 2019-09-30 | $115.80M 10-Q · filed 2020-11-02 | $224.30M derived: sum of 2 quarters · filed 2020-11-02 | $345.50M 10-Q · filed 2020-11-02 | $389.60M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-06-30 | $108.50M 10-Q · filed 2020-07-31 | $229.70M 10-Q · filed 2020-07-31 | $273.80M derived: sum of 3 quarters · filed 2021-02-26 | $379.30M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-03-31 | $121.20M 10-Q · filed 2020-05-11 | $165.30M derived: sum of 2 quarters · filed 2021-02-26 | $270.80M derived: sum of 3 quarters · filed 2021-02-26 | $380.30M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2018-12-31 | $44.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $149.60M derived: sum of 2 quarters · filed 2021-02-26 | $259.10M derived: sum of 3 quarters · filed 2021-02-26 | $361.50M 10-K · filed 2021-02-26 | |
| 2018-09-30 | $105.50M 10-Q · filed 2019-10-31 | $215.00M derived: sum of 2 quarters · filed 2019-10-31 | $317.40M 10-Q · filed 2019-10-31 | $410.70M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-06-30 | $109.50M 10-Q · filed 2019-07-31 | $211.90M 10-Q · filed 2019-07-31 | $305.20M derived: sum of 3 quarters · filed 2020-02-27 | $386.10M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-03-31 | $102.40M 10-Q · filed 2019-05-01 | $195.70M derived: sum of 2 quarters · filed 2020-02-27 | $276.60M derived: sum of 3 quarters · filed 2020-02-27 | $353.40M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2017-12-31 | $93.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $174.20M derived: sum of 2 quarters · filed 2020-02-27 | $251.00M derived: sum of 3 quarters · filed 2020-02-27 | $332.30M 10-K · filed 2020-02-27 | $317.50M 10-K · filed 2018-02-28 |
| 2017-09-30 | $80.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $157.70M derived: sum of 2 quarters · filed 2018-10-31 | $239.00M 10-Q · filed 2018-10-31 | $318.20M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-06-30 | $76.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $158.10M 10-Q · filed 2018-08-02 | $237.30M derived: sum of 3 quarters · filed 2019-02-27 | $311.70M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-03-31 | $81.30M 10-Q · filed 2018-05-02 | $160.50M derived: sum of 2 quarters · filed 2019-02-27 | $234.90M derived: sum of 3 quarters · filed 2019-02-27 | $312.50M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2016-12-31 | $79.20M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $153.60M derived: sum of 2 quarters · filed 2019-02-27 | $231.20M derived: sum of 3 quarters · filed 2019-02-27 | $304.00M 10-K · filed 2019-02-27 | |
| 2016-09-30 | $74.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $152.00M derived: sum of 2 quarters · filed 2017-10-31 | $224.80M 10-Q · filed 2017-10-31 | $286.90M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2016-06-30 | $77.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $150.40M 10-Q · filed 2017-08-02 | $212.50M derived: sum of 3 quarters · filed 2018-02-28 | $276.60M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2016-03-31 | $72.80M 10-Q · filed 2017-04-28 | $134.90M derived: sum of 2 quarters · filed 2018-02-28 | $199.00M derived: sum of 3 quarters · filed 2018-02-28 | $255.70M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2015-12-31 | $62.10M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $126.20M derived: sum of 2 quarters · filed 2018-02-28 | $182.90M derived: sum of 3 quarters · filed 2018-02-28 | $239.00M 10-K · filed 2018-02-28 | |
| 2015-09-30 | $64.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $120.80M derived: sum of 2 quarters · filed 2016-10-28 | $176.90M 10-Q · filed 2016-10-28 | $233.20M derived: sum of 4 quarters · filed 2017-09-19 | |
| 2015-06-30 | $56.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $112.80M 10-Q · filed 2016-07-29 | $169.10M derived: sum of 3 quarters · filed 2017-09-19 | $232.10M derived: sum of 4 quarters · filed 2017-09-19 | |
| 2015-03-31 | $56.10M 10-Q · filed 2016-04-28 | $112.40M derived: sum of 2 quarters · filed 2017-09-19 | $175.40M derived: sum of 3 quarters · filed 2017-09-19 | $271.70M derived: sum of 4 quarters · filed 2017-09-19 | |
| 2014-12-31 | $56.30M derived: 8-K 12 month − 10-Q 9 month · filed 2017-09-19 | $119.30M derived: sum of 2 quarters · filed 2017-09-19 | $215.60M derived: sum of 3 quarters · filed 2017-09-19 | $275.10M 8-K · filed 2017-09-19 | |
| 2014-09-30 | $63.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $159.30M derived: sum of 2 quarters · filed 2015-10-29 | $218.80M 10-Q · filed 2015-10-29 | $281.30M derived: sum of 4 quarters · filed 2016-02-25 | |
| 2014-06-30 | $96.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $155.80M 10-Q · filed 2015-07-30 | $218.30M derived: sum of 3 quarters · filed 2016-02-25 | ||
| 2014-03-31 | $59.50M 10-Q · filed 2015-05-01 | $122.00M derived: sum of 2 quarters · filed 2016-02-25 | |||
| 2013-12-31 | $62.50M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $375.60M 10-K · filed 2016-02-25 | |||
| 2013-09-30 | $313.10M 10-Q · filed 2014-10-28 | ||||
| 2012-12-31 | $232.10M 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |